Phase 1b clinical trial of TG1050 a novel HBV-targeted immunotherapy in NUC suppressed chronic hepatitis B (CHB) patients: safety and early immunological data following single administration
HEPATOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要